BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22733123)

  • 1. Predicting the continuous values of breast cancer relapse time by type-2 fuzzy logic system.
    Mahmoodian H
    Australas Phys Eng Sci Med; 2012 Jun; 35(2):193-204. PubMed ID: 22733123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using fuzzy association rule mining in cancer classification.
    Mahmoodian H; Hamiruce Marhaban M; Abdulrahim R; Rosli R; Saripan I
    Australas Phys Eng Sci Med; 2011 Apr; 34(1):41-54. PubMed ID: 21327594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantifier-based fuzzy classification system for breast cancer patients.
    Soria D; Garibaldi JM; Green AR; Powe DG; Nolan CC; Lemetre C; Ball GR; Ellis IO
    Artif Intell Med; 2013 Jul; 58(3):175-84. PubMed ID: 23791088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical application of fuzzy association rules for identifying breast cancer biomarkers.
    Lopez FJ; Cuadros M; Cano C; Concha A; Blanco A
    Med Biol Eng Comput; 2012 Sep; 50(9):981-90. PubMed ID: 22622817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided diagnosis system based on fuzzy logic for breast cancer categorization.
    Miranda GH; Felipe JC
    Comput Biol Med; 2015 Sep; 64():334-46. PubMed ID: 25453323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a genetic-fuzzy algorithm as a computer aided diagnosis tool on Saudi Arabian breast cancer database.
    Alharbi A; Tchier F
    Math Biosci; 2017 Apr; 286():39-48. PubMed ID: 28185926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable Gene Signature Selection for Prediction of Breast Cancer Recurrence Using Joint Mutual Information.
    Sehhati M; Mehridehnavi A; Rabbani H; Pourhossein M
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1440-8. PubMed ID: 26671813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A risk management model for familial breast cancer: A new application using Fuzzy Cognitive Map method.
    Papageorgiou EI; Jayashree Subramanian ; Karmegam A; Papandrianos N
    Comput Methods Programs Biomed; 2015 Nov; 122(2):123-35. PubMed ID: 26220142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
    Kempowsky-Hamon T; Valle C; Lacroix-Triki M; Hedjazi L; Trouilh L; Lamarre S; Labourdette D; Roger L; Mhamdi L; Dalenc F; Filleron T; Favre G; François JM; Le Lann MV; Anton-Leberre V
    BMC Med Genomics; 2015 Feb; 8():3. PubMed ID: 25888889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of fuzzy classification methods on breast cancer data.
    Jain R; Abraham A
    Australas Phys Eng Sci Med; 2004 Dec; 27(4):213-8. PubMed ID: 15712589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory consensus of hierarchical clusterings for melanoma and breast cancer.
    Mahata P
    IEEE/ACM Trans Comput Biol Bioinform; 2010; 7(1):138-52. PubMed ID: 20150676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering biomarkers from gene expression data for predicting cancer subgroups using neural networks and relational fuzzy clustering.
    Pal NR; Aguan K; Sharma A; Amari S
    BMC Bioinformatics; 2007 Jan; 8():5. PubMed ID: 17207284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new hybrid method based on fuzzy-artificial immune system and k-nn algorithm for breast cancer diagnosis.
    Sahan S; Polat K; Kodaz H; Güneş S
    Comput Biol Med; 2007 Mar; 37(3):415-23. PubMed ID: 16904096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interpretable fuzzy rule-based classification methodology for medical diagnosis.
    Gadaras I; Mikhailov L
    Artif Intell Med; 2009 Sep; 47(1):25-41. PubMed ID: 19540096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns.
    Cadoo KA; Fornier MN; Morris PG
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):312-21. PubMed ID: 24322788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting breast cancer survivability using fuzzy decision trees for personalized healthcare.
    Khan MU; Choi JP; Shin H; Kim M
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5148-51. PubMed ID: 19163876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary fuzzy modeling human diagnostic decisions.
    Peña-Reyes CA
    Ann N Y Acad Sci; 2004 May; 1020():190-211. PubMed ID: 15208193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified interval type-2 fuzzy neural networks.
    Lin YY; Liao SH; Chang JY; Lin CT
    IEEE Trans Neural Netw Learn Syst; 2014 May; 25(5):959-69. PubMed ID: 24808041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast-cancer identification using HMM-fuzzy approach.
    Hassan MR; Hossain MM; Begg RK; Ramamohanarao K; Morsi Y
    Comput Biol Med; 2010 Mar; 40(3):240-51. PubMed ID: 20152962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.